5-Amino-1MQ is a laboratory research material used to study NNMT-related metabolic pathways, nicotinamide handling, NAD+ homeostasis, and cellular energy regulation in controlled experimental systems
doi: 10.1208/s12248-013-9465-7
AHK-Cu is a copper-binding tripeptide studied for its role in cell signaling, extracellular matrix regulation, and tissue-repair pathways
Individuals with Digestive Disorders Conditions like Crohns disease, celiac disease, or gastric bypass surgery can impair B12 absorption
Additionally, analogues containing the quinolinium scaffold lacked inhibitory activity against enzymes in the NAD + salvage pathway that bind nicotinamide-containing substrate, including NAMPT[27, 32] and the NAD + -dependent SIRT1 enzyme, which deacetylates NAD + to produce NA, a product inhibitor of SIRT1.[33] These results suggest that quinolinium-based NNMT inhibitors achieve selectivity by specifically interacting with the NA-binding pocket of NNMT,[17] unlike several known non-selective methyltransferase inhibitors that interact with the SAM-binding pocket, which is highly conserved among SAM-dependent methyltransferases.[34, 35] Membrane-permeable NNMT inhibitors reduced intracellular 1-MNA levels in a concentration-dependent manner and at pharmacologically relevant concentrations that did not impact cell viability, suggesting these small molecules interact directly with NNMT in cells
